title: Oral idarubicin as a palliative agent in leukemia.
authors.affiliation: IRCF Department of Medical Oncology, St Bartholomew's Hospital, London, U.K.
authors.forename: C L
authors.initials: CL
authors.lastname: Davis
authors.forename: A Z
authors.initials: AZ
authors.lastname: Rohatiner
authors.forename: J A
authors.initials: JA
authors.lastname: Amess
authors.forename: T A
authors.initials: TA
authors.lastname: Lister
mesh_terms: D000284:Administration, Oral; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D007938:Leukemia / Q000188:drug therapy*; D010166:Palliative Care
chemical_list: D015255:Idarubicin